Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Procurement topic

No spam. Unsubscribe anytime.

Board approves Navis amendment on pharmacy benefit manager; staff to seek legislative guidance on rebates

State Board of Finance · October 25, 2023
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

The board approved an amendment to the Navis pharmacy benefit manager procurement that strengthens data security and confidentiality language and requires follow-up with the AOC for guidance on rebate/reimbursement issues; motion was made by Autumn Oden and seconded by Secretary Fiskin.

Board staff presented an amendment to the Navis RFP and best-and-final-offer materials used for the state’s pharmacy benefit manager procurement. The amendment is described in the presentation as a supplement to — not a replacement for — the underlying RFP and final-offer documents. It clarifies terms, definitions and adds stronger, more current language around data security and confidentiality.

When asked whether the amendment required legislative approval, staff said yes and said the next step after board approval would be to take the amendment to AOC (the relevant legislative review body) for direction, particularly on pharmacy rebate and reimbursement issues that the staff identified as outside the scope of the amendment. Staff said the rebate and reimbursement items will require additional guidance from AOC and potentially a separate legislative conversation.

Autumn Oden moved to approve the amendment; Secretary Fiskin seconded, and the board approved the amendment by voice vote. The transcript records ayes and the chair declaring the motion carried but does not provide a roll‑call tally.

What’s next: Staff to submit the approved amendment to AOC for any required legislative review and to pursue guidance on pharmacy rebate/reimbursement issues before final implementation.